Equity Overview
Price & Market Data
Price: $0.165
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $53,912,740
Daily Volume: 0
Performance Metrics
1 Week: -4.01%
1 Month: -14.32%
3 Months: -39.94%
6 Months: -31.44%
1 Year: -88.99%
YTD: -23.92%
Company Details
Employees: 139
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases. The company develops vaccines for the treatment cancer, autoimmune, and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of locally advanced and metastatic tumors; and VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer. Nykode Therapeutics AS was founded in 2006 and is headquartered in Oslo, Norway.